Pyridostigmine ๐
โ ๏ธ Important: Pyridostigmine increases acetylcholine at the neuromuscular junction.
In excess, it can cause a cholinergic crisis (depolarising block), which may mimic worsening myasthenia.
Avoid in patients with severe asthma.
๐ About
- Check full details in the BNF here.
- Often useful for patients who are weakest on waking (short-term symptomatic relief).
โ๏ธ Mode of Action
- Reversible acetylcholinesterase inhibitor โ โ acetylcholine at neuromuscular junction.
- Less potent than neostigmine but longer duration of action.
- In excess, may worsen weakness (cholinergic crisis).
๐ Dose Range (monitor LFTs)
| Name |
Starting Dose |
Frequency |
Route |
| Pyridostigmine (for Myasthenia) |
30โ120 mg |
QDS |
PO (max 450 mg/day usual; up to 1.2 g/day sometimes used).
Consider adding immunosuppression if dose >360 mg/day. |
๐ Interactions
- See BNF for full details (many possible interactions).
โ ๏ธ Cautions
- Asthma (extreme caution)
- Bradycardia, arrhythmias, recent MI
- Epilepsy, hypotension, parkinsonism
- Peptic ulcer disease, hyperthyroidism
๐ซ Contraindications
- Bowel obstruction
- Urinary obstruction
โ Side Effects
- Excess muscarinic activity: sweating, colic, diarrhoea, salivation, gastric hypersecretion, bradycardia.
- Effects can be reversed with atropine-like drugs.
๐ References
- BNF Online: Pyridostigmine Bromide
- Clinical Pharmacology texts